Nicolas Chapuis

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore et al. · Cell · 2020 · 920 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +5

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition

Nathalie Jacque, Anne Marie Ronchetti, Clément Larrue et al. · Blood · 2015 · 384 citations · Full text

Medicine, Oncology, Pharmacology +16

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia

Lise Willems, Nathalie Jacque, Arnaud Jacquel et al. · Blood · 2013 · 286 citations

Medicine, Oncology, Pharmacology +8

Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways

Jérôme Tamburini, Nicolas Chapuis, Valérie Bardet et al. · Blood · 2007 · 252 citations

Medicine, Oncology, Pharmacology +16

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation

Alexa S. Green, Nicolas Chapuis, Thiago Trovati Maciel et al. · Blood · 2010 · 197 citations · Full text

Life Sciences, Molecular Biology, Oncology +16